SLC5A5 and neoplasm: This tumor tropism of MSCs has been used as a “Trojan Horse”-like therapy approach in which genetically engineered MSCs deliver a therapeutic agent, in our case the NIS gene, deeply into growing tumors 34-37, 39-41, 43, 71-74.